P-gp (P-glycoprotein; ABCB1) protects us by transporting a broad range of structurally unrelated compounds out of the cell. Identifying the regions of P-gp that make up the drug-binding pocket is important for understanding the mechanism of transport. The common drug-binding pocket is at the interface between the transmembrane domains of the two homologous halves of P-gp. It has been shown in a previous study [Loo, Bartlett and Clarke (2006) Biochem. J. 396, 537–545] that the first transmembrane segment (TM1) contributed to the drug-binding pocket. In the present study, we used cysteine-scanning mutagenesis, reaction with an MTS (methanethiosulfonate) thiol-reactive analogue of verapamil (termed MTS–verapamil) and cross-linking analysis to test whether the equivalent transmembrane segment (TM7) in the C-terminal-half of P-gp also contributed to drug binding. Mutation of Phe728 to cysteine caused a 4-fold decrease in apparent affinity for the drug substrate verapamil. Mutant F728C also showed elevated ATPase activity (11.5-fold higher than untreated controls) after covalent modification with MTS–verapamil. The activity returned to basal levels after treatment with dithiothreitol. The substrates, verapamil and cyclosporin A, protected the mutant from labelling with MTS–verapamil. Mutant F728C could be cross-linked with a homobifunctional thiol-reactive cross-linker to cysteines I306C(TM5) and F343C(TM6) that are predicted to line the drug-binding pocket. Disulfide cross-linking was inhibited by some drug substrates such as Rhodamine B, calcein acetoxymethyl ester, cyclosporin, verapamil and vinblastine or by vanadate trapping of nucleotides. These results indicate that TM7 forms part of the drug-binding pocket of P-gp.
Skip Nav Destination
Article navigation
October 2006
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
September 27 2006
Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket
Tip W. Loo;
Tip W. Loo
*Department of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 1A8
†Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Search for other works by this author on:
M. Claire Bartlett;
M. Claire Bartlett
*Department of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 1A8
†Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada M5S 1A8
Search for other works by this author on:
David M. Clarke
David M. Clarke
1
*Department of Medicine, University of Toronto, Toronto, Ontario, Canada M5S 1A8
†Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada M5S 1A8
1To whom correspondence should be addressed, at Department of Medicine, University of Toronto, Ontario, Canada M5S 1A8 (email david.clarke@utoronto.ca).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 16 2006
Revision Received:
June 20 2006
Accepted:
July 03 2006
Accepted Manuscript online:
July 03 2006
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London
2006
Biochem J (2006) 399 (2): 351–359.
Article history
Received:
May 16 2006
Revision Received:
June 20 2006
Accepted:
July 03 2006
Accepted Manuscript online:
July 03 2006
Citation
Tip W. Loo, M. Claire Bartlett, David M. Clarke; Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket. Biochem J 15 October 2006; 399 (2): 351–359. doi: https://doi.org/10.1042/BJ20060715
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.